Ireland
--:--IST
Starting soon Not applicable

Early Mobilisation and Relational Touch Practice on Intubated Patients of Intensive Care Unit

NCT05903378 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2025-12
Last updated
2025-04-06

Condition(s) studied

Ventilation Therapy

Investigational drug(s) / intervention(s)

Relational touch practice

Relational touch practice: Relational touch practice during the first bedside session. Touch in care aims to improve the patient's perception of potentially painful or anxiety-provoking acts of care. It is based on techniques of skin contact, developing and deepening.

Study summary

41.3% of patients hospitalized in intensive care express feeling anxiety when they are systematically questioned. Ventilatory weaning is one of the moments of anxiety for the patient. While being conscious he must tolerate invasive ventilation. The early mobilization of patients in intensive care must be started early, within 24-48 hours, after the patient wakes up. Early mobilization is part of the weaning process from invasive mechanical ventilation in intensive care. It is recommended to reduce it to use relaxation therapies. Several studies have assessed the impact of relational touch in conscious or unconscious patients in intensive care. The SRLF consensus conference in 2010 recommends the use of massage for anxiolytic purposes.

This study aims to assess the impact of relational touch versus standard care on anxiety during the first bedside session, in intubated intensive care patients ventilated for at least 48 hours and presenting with RASS (Richmond agitation sedation scale). ) from 0 to -1.

The study will aussi assess the impact of relational touch versus standard care on the following patient parameters:

* Evaluation of caregiver anxiety with the Spielberger inventory before and after the session
* Increasing the duration of the bedside session;
* Variations in pain, assessed by the Behavioral Pain Scale (BPS) at the end of the session;
* The level of agitation/vigilance at the beginning and at the end of the session with the Richmond agitation-sedation scale (RASS);
* Induced variations in blood pressure;
* Induced variations in oxygen saturation;
* The variations induced on the respiratory rate;
* The variations induced on the heart rate;
* The need to prescribe psychotropic drugs on the day of the first bedside;
* Reduction in the number of days of invasive mechanical ventilation between the first bedside session and discharge from intensive care unit (maximum D28 after the first bedside session).

This is a national, multicenter, cluster, randomized, controlled trial with 4-stage stepped-wedge design (1:1:1:1 randomization), phase III, superiority, open-label, comparing systematic practice relational touch by the paramedical team during bedside sessions, versus standard care (without relational touch).

The benefit is above all for the patient with a better experience of bedside sessions and a reduction in ventilation time, therefore bed rest, leading to a reduction in decubitus complications. The expected economic benefit involves the reduction of decubitus complications and therefore their cost and the reduction of hospitalization times in intensive care.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Adult patient ventilated invasively for at least 48 hours, RASS between 0 and -1 with early mobilization prescribed but not performed. Exclusion Criteria: * Patient needing help from another person to mobilizing * Patient with an unstable fracture * Patient with a recent laparotomy (less than 10 days) * Patient under judicial protection measures * Patient on catecholamines * Pregnant or breastfeeding woman * Non-communicating patient due to neuropsychiatric pathology * Patient benefiting from a process of palliative care or moribund patient whose estimated life expectancy is less than 30 days * Strict bed rest order * Fraction inspired oxygen (FIO2) \>50% * Body mass index \> 40 Kg/m2 * Patient having an epidural with motor impairment.

Primary outcome measure(s)

  • Evaluation of patients' anxiety — at baseline
    With the Face Anxiety Scale, anxiety lever of patients will be assessed.

Trial sites (1)

FacilityCityRegionStatus
ICU, Ambroise Paré Hospital - APHP Boulogne-Billancourt France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05903378 on ClinicalTrials.gov ↗ ← All trials in France